# Novo Nordisk A/S – FDA Inspection, Sep 3, 2013

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/d4ee5da4-3a33-41c2-bf98-f33b8e2cca57
Source feed: FDA_Inspections

> FDA inspection 846713 of Novo Nordisk A/S, September 03, 2013. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 846713
- Company Name: Novo Nordisk A/S
- Inspection Date: 2013-09-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1245306 - 2023-03-29
- [FDA Inspection 1165895 - 2019-12-05](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/1b2e0386-bb32-4a1e-b8c0-6bda25e404ad)
- FDA Inspection 1057438 - 2018-05-18
- [FDA Inspection 1007260 - 2017-02-08](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/f7c9c747-d7de-4a6c-9886-e185d08b2706)
- FDA Inspection 964462 - 2016-04-08

Company: https://www.keypedia.com/companies/novo-nordisk-as/99c36868-1f84-44c1-8e90-7abc30e92ec3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c